Read the full press release from BusinessWire here. BioForward names biohealth industry leaders to Board of Directors MADISON, Wis.–(BUSINESS WIRE)–BioForward, Wisconsin’s state association representing over 220 biohealth member companies, announced seven additions to this year’s Board of Directors. The board of eighteen represents many facets of the state’s diverse biohealth industry and focuses on uniting […]
Read the full press release here. Promega Corporation today announced it has signed a license agreement with MilliporeSigma, a leader in genome editing, to access MilliporeSigma’s foundational CRISPR genome-editing technology. Under the agreement, Promega will create new research products for investigating endogenous biology, including those for drug development. These tools will allow researchers to better […]
Read the full press release from BusinessWire here. TAI Diagnostics Announces New Publication using the myTAIHEART® Test in The Journal of Heart and Lung Transplantation TAI Diagnostics, Inc., focused on developing innovative diagnostic tests for monitoring the health of transplanted organs, today announced the publication of “Donor Fraction Cell-Free DNA and Rejection in Adult and […]
Read the full story from BizTimes here. Madison-based cancer diagnostics company Exact Sciences Corp. completed its $2.8 billion cash-and-stock deal with Redwood City, California-based Genomic Health, the company announced. Exact Sciences produces Cologuard, a noninvasive, at-home screening test that detects the presence of colon cancer in stool samples. Genomic Health develops Oncotype IQ, a portfolio of genomic […]
Read the full story from Fierce Biotech here. Merck & Co. will work with Promega to develop the biological analysis company’s microsatellite instability technology into an official, on-label companion diagnostic for its Keytruda immunotherapy in solid tumors. The global collaboration will start with its eyes on regulatory approvals in the U.S. and China, plus the […]
Read the full press release from BusinessWire here. Imbed Biosciences Inc. (Imbed), a privately held biotech company emerging as a leader in the development of advanced therapies for burns, chronic ulcers and surgical wounds, announced today that it has closed its Series A Preferred Stock equity financing, which was expanded to $4 million due to […]
Read the full press release from Promentis Pharmaceuticals here. Promentis Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing innovative therapies for neuropsychiatric disorders, today announced it has successfully completed a behavioral biomarker study for its lead compound, SXC-2023, and has finished enrolling patients in a Phase 2 multi-center study in its first indication, trichotillomania. Promentis is developing […]
Read the full press release on BusinessWire here. TAI Diagnostics, Inc., focused on developing innovative diagnostic tests for monitoring the health of transplanted organs, today announced the publication, “Effect of endomyocardial biopsy on levels of donor-specific cell-free DNA” in the October, 2019 issue of The Journal of Heart and Lung Transplantation. The clinical study presented in the paper was […]
Read the full story from BizTimes here. Advocate Aurora Health broke ground Wednesday to celebrate the start of construction for its planned $228 million development in Mount Pleasant. The project will include a 198,000-square-foot medical center and 98,000-square-foot medical office building on a 96-acre complex located northeast of I-94 and Highway 20 in Mount Pleasant. The medical […]
Read the full story from Illumina here. October 21, 2019 In October 2014, Illumina Accelerator announced the inaugural class of companies to join the world’s first business accelerator focused on creating an innovation ecosystem for the genomics industry. Illumina Accelerator’s goal is to build high-growth, venture-backable companies focused on advancing breakthrough applications in genomics to transform human […]